These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1897623)

  • 1. Intravenous dexamethasone for symptoms of major depressive disorder.
    Arana GW
    Am J Psychiatry; 1991 Oct; 148(10):1401-2. PubMed ID: 1897623
    [No Abstract]   [Full Text] [Related]  

  • 2. Dexamethasone for depression.
    Wolkowitz OM; Reus VI; Manfredi F; Chan T; Ormiston S; Johnson R
    Am J Psychiatry; 1996 Aug; 153(8):1112; author reply 1112-3. PubMed ID: 8678190
    [No Abstract]   [Full Text] [Related]  

  • 3. Dexamethasone for the treatment of depression: a preliminary report.
    Arana GW; Forbes RA
    J Clin Psychiatry; 1991 Jul; 52(7):304-6. PubMed ID: 2071561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone for the treatment of depression: a randomized, placebo-controlled, double-blind trial.
    Arana GW; Santos AB; Laraia MT; McLeod-Bryant S; Beale MD; Rames LJ; Roberts JM; Dias JK; Molloy M
    Am J Psychiatry; 1995 Feb; 152(2):265-7. PubMed ID: 7840362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone for treatment of major depression in patients with bipolar disorder.
    Beale MD; Arana GW
    Am J Psychiatry; 1995 Jun; 152(6):959-60. PubMed ID: 7755142
    [No Abstract]   [Full Text] [Related]  

  • 6. Dexamethasone for depression.
    Mitchell AJ
    Am J Psychiatry; 1996 Aug; 153(8):1111-2; author reply 1112-3. PubMed ID: 8678189
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of dexamethasone in elderly patients with antidepressant-resistant depressive illness.
    Bodani M; Sheehan B; Philpot M
    J Psychopharmacol; 1999; 13(2):196-7. PubMed ID: 10475727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cortisol secretion rate 16 hours after dexamethasone administration in patients with major depression].
    Wichowicz H; Landowski J; Sowiński P
    Psychiatr Pol; 1997; 31(4):471-7. PubMed ID: 9527690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravenous administration of dexamethasone in the treatment of alcohol withdrawal syndrome.
    Davido A; Cadranel JF; Levy A; Benhamou Y; Gargot D; Leplat P; Valla D; Opolon P
    J Clin Gastroenterol; 1994 Mar; 18(2):178-9. PubMed ID: 8189026
    [No Abstract]   [Full Text] [Related]  

  • 10. Mood response to methylphenidate and the Dexamethasone Suppression Test as predictors of treatment response to zimelidine and lithium in major depression.
    Joyce PR
    Biol Psychiatry; 1985 Jun; 20(6):598-604. PubMed ID: 3158354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological differences in endogenous depressive placebo responders versus nonresponders: dexamethasone suppression test and sleep EEG data.
    Zammit GK; Rosenbaum AH; Stokes P; Davis J; Zorick F; Roth T
    Biol Psychiatry; 1988 May; 24(1):97-101. PubMed ID: 3370281
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma dexamethasone kinetics during the DST after oral and intravenous administration of the test drug.
    Wiedemann K; Holsboer F
    Biol Psychiatry; 1987 Nov; 22(11):1340-8. PubMed ID: 3663786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone for the treatment of depression.
    Coplan JD; Taylor L; Gorman JM
    J Clin Psychiatry; 1992 Aug; 53(8):293. PubMed ID: 1500407
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma dexamethasone levels in depression: oral vs. i.v. administration.
    Wiedemann K; Holsboer F
    Psychiatry Res; 1987 Jan; 20(1):83-5. PubMed ID: 3562694
    [No Abstract]   [Full Text] [Related]  

  • 15. Lithium treatment and serotoninergic function. Neuroendocrine and behavioral responses to intravenous tryptophan in affective disorder.
    Price LH; Charney DS; Delgado PL; Heninger GR
    Arch Gen Psychiatry; 1989 Jan; 46(1):13-9. PubMed ID: 2910219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating endogenous depression.
    von Oldenburg A
    Mil Med; 1990 Mar; 155(3):A8. PubMed ID: 2107462
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolactin, cortisol, and antidepressant treatment.
    Fava GA; Lisansky J; Buckman MT; Kellner R; Pathak D; Fava M; Peake GT
    Am J Psychiatry; 1988 Mar; 145(3):358-60. PubMed ID: 3344852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose infusion therapy for severe depressions.
    Magyar I; Mód L; Alföldi A; Arató M
    Pharmacopsychiatry; 1988 Mar; 21(2):93-7. PubMed ID: 2899330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone suppression test and mood response to methylphenidate in primary depression.
    Brown P; Brawley P
    Am J Psychiatry; 1983 Aug; 140(8):990-3. PubMed ID: 6346911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocortical sensitivity to low-dose ACTH administration in depressed patients.
    Krishnan KR; Ritchie JC; Saunders WB; Nemeroff CB; Carroll BJ
    Biol Psychiatry; 1990 Apr; 27(8):930-3. PubMed ID: 2331499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.